Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Europe (Primary) | PRIMARYEUR | Univ | 6,293 | 20,431,056 | -0.13% | 1.63% | 3.08% | 3.91% | 14.73% | 13.86% |
Healthcare | HEALTHCARE | Sector | 584 | 2,263,244 | -0.59% | 6.29% | 4.03% | 6.71% | 13.32% | -6.40% |
Biopharmaceuticals | BIOPHARMA | SubSec | 181 | 1,756,713 | -0.59% | 7.32% | 5.66% | 9.47% | 15.53% | -6.52% |
Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 53 | 41,923 | -0.89% | 4.93% | 9.62% | 30.96% | 41.01% | 19.86% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 11 | 4,935 | -0.57% | -0.01% | 3.91% | 29.62% | 43.57% | 14.66% |
Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
---|---|---|---|---|---|---|---|---|---|---|
Valneva SE | VLA:FRAVLA:FRA | Stock | 1 | 870 | -5.54% | -7.11% | 28.49% | 82.83% | 64.29% | 83.12% |
Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 781 | 4.10% | 7.40% | 9.25% | 5.28% | 27.96% | 13.01% |
Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 11 | 4,935 | -0.57% | -0.01% | 3.91% | 29.62% | 43.57% | 14.66% |
Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,293 | 20,431,056 | -0.14% | 2.24% | 3.31% | 4.57% | 18.85% | 12.06% |
Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 2,789 | -0.17% | 0.53% | -2.96% | 27.06% | 60.39% | 1.59% |
* Colors indicate performance relative to the benchmark.